| Remdesivir for the treatment of Covid-19—preliminary report JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1836, 2020 | 8131 | 2020 |
| Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient SWX Ong, YK Tan, PY Chia, TH Lee, OT Ng, MSY Wong, K Marimuthu Jama 323 (16), 1610-1612, 2020 | 3012 | 2020 |
| Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore BE Young, SWX Ong, S Kalimuddin, JG Low, SY Tan, J Loh, OT Ng, ... Jama 323 (15), 1488-1494, 2020 | 2570 | 2020 |
| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1753 | 2021 |
| Remdesivir for 5 or 10 days in patients with severe Covid-19 JD Goldman, DCB Lye, DS Hui, KM Marks, R Bruno, R Montejano, ... New England Journal of Medicine 383 (19), 1827-1837, 2020 | 1609 | 2020 |
| Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients PY Chia, KK Coleman, YK Tan, SWX Ong, M Gum, SK Lau, XF Lim, ... Nature communications 11 (1), 2800, 2020 | 986* | 2020 |
| Clinical and virological features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern: a retrospective cohort study comparing B. 1.1. 7 (Alpha … SWX Ong, CJ Chiew, LW Ang, TM Mak, L Cui, MPHS Toh, YD Lim, ... Clinical Infectious Diseases 75 (1), e1128-e1136, 2022 | 491* | 2022 |
| Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study PY Chia, SWX Ong, CJ Chiew, LW Ang, JM Chavatte, TM Mak, L Cui, ... Clinical microbiology and infection 28 (4), 612. e1-612. e7, 2022 | 396 | 2022 |
| Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study WN Chia, F Zhu, SWX Ong, BE Young, SW Fong, N Le Bert, CW Tan, ... The Lancet Microbe 2 (6), e240-e249, 2021 | 372 | 2021 |
| A neutralizing monoclonal antibody for hospitalized patients with Covid-19 Activ-3/Tico Ly-CoV555 Study Group New England Journal of Medicine 384 (10), 905-914, 2021 | 328 | 2021 |
| Viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory aerosols emitted by patients with coronavirus disease 2019 (COVID-19) while breathing … KK Coleman, DJW Tay, KS Tan, SWX Ong, TS Than, MH Koh, YQ Chin, ... Clinical Infectious Diseases 74 (10), 1722-1728, 2022 | 220* | 2022 |
| Viral dynamics and immune correlates of coronavirus disease 2019 (COVID-19) severity BE Young, SWX Ong, LFP Ng, DE Anderson, WN Chia, PY Chia, LW Ang, ... Clinical Infectious Diseases 73 (9), e2932-e2942, 2021 | 200 | 2021 |
| Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial AC Kalil, AK Mehta, TF Patterson, N Erdmann, CA Gomez, MK Jain, ... The lancet respiratory medicine 9 (12), 1365-1376, 2021 | 139 | 2021 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 122 | 2022 |
| Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients SWX Ong, SW Fong, BE Young, YH Chan, B Lee, SN Amrun, RSL Chee, ... Open forum infectious diseases 8 (6), ofab156, 2021 | 92 | 2021 |
| Absence of contamination of personal protective equipment (PPE) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) SWX Ong, YK Tan, S Sutjipto, PY Chia, BE Young, M Gum, SK Lau, ... Infection Control & Hospital Epidemiology 41 (5), 614-616, 2020 | 92 | 2020 |
| Diabetes and overweight/obesity are independent, nonadditive risk factors for in-hospital severity of COVID-19: an international, multicenter retrospective meta-analysis DK Longmore, JE Miller, S Bekkering, C Saner, E Mifsud, Y Zhu, R Saffery, ... Diabetes Care 44 (6), 1281-1290, 2021 | 79 | 2021 |
| Association of higher body mass index with severe coronavirus disease 2019 (COVID-19) in younger patients SWX Ong, BE Young, YS Leo, DC Lye Clinical Infectious Diseases 71 (16), 2300-2302, 2020 | 70 | 2020 |
| Responses to a neutralizing monoclonal antibody for hospitalized patients with COVID-19 according to baseline antibody and antigen levels: a randomized controlled trial ACTIV-3/TICO Bamlanivimab Study Group* Annals of internal medicine 175 (2), 234-243, 2022 | 56 | 2022 |
| Predictors for development of critical illness amongst older adults with COVID-19: Beyond age to age-associated factors JP Lim, KYH Low, NJJ Lin, CZQ Lim, SWX Ong, WYT Tan, WC Tay, ... Archives of gerontology and geriatrics 94, 104331, 2021 | 40 | 2021 |
David LyeNational Centre for Infectious Diseases; Tan Tock Seng Hospital; Lee Kong Chian School of MedicineVerified email at ttsh.com.sg
